|
|
|
Cervical Cancer Screening Tables |
|
Cervical Cancer Screening
|
| Burden of Disease |
Mortality1
4,000 U.S. women die each year from cervical cancer |
Incidence2
9,700 U.S. women will be diagnosed with cervical cancer each year |
Effectiveness
|
Effectiveness of screening in reducing cervical cancer deaths is 66%3
|
Improvability
|
Screening Rates4
76% of adult women have had a Pap smears for screening purposes in the past 3 years.
Guide to Community Preventive Services Recommendations5
Numerous interventions are effective at improving early detection and control of cancer. |
| Cost6 |
Annual Per Person Medical Cost of Service: $40 |
| Annual Per Person Medical Cost of Savings: $8 |
| Annual Net Costs: $32 |
| % of Service Recovered in Long Run: 20% |
Sources and Footnotes:
1. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.1.4. Surveillnace, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality - All COD, Public-Use With State, Total U.S. (1969-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
2. American Cancer Society, Cancer Facts and Figures 2006. Atlanta: American Cancer Society; 2006.
3. Refer to the technical report on cervical cancer for a fuller discussion of these data and references.
4. NHIS 2003 Sample Adult Core Survey.
5. Guide to Community Preventive Services Website.
6. Five notes on costs and savings: 1) Costs and savings are expressed in year 2005 dollars. 2) Costs and savings are expressed as the per person cost per year over the recommended age range to facilitate use in estimating long-term budget impact. 3) Costs and savings are not discounted to facilitate use in estimating long-term budget impact. As a result, they are not comparable to estimates that would be used in formal cost-effectiveness analysis. Services that are cost-saving from a budgetary perspective may not be cost-saving in an economic analysis that discounts future events to their present value. 4) Costs and savings reflect non-adherence and the recommended frequency of delivery. Therefore, services with less frequent intervals or with lower adherence would have a lower cost than an otherwise identical service. 5) Costs reflect both initial preventive service costs (such as screening and counseling) and necessary follow-up costs such as diagnostic testing, pharmacotherapy, and intensive interventions for weight loss.
|
Mortality
|
| |
US Women (All Ages)
|
US Women (20 years and older)
|
| |
Total Deaths
|
Rate per 100,000
|
Total Deaths
|
Rate per 100,000
|
US Population
|
3,952 |
2.8 |
3,951 |
3.8 |
| Race/Ethnicity |
|
|
|
|
|
White
|
2,967
|
2.8
|
2,967
|
3.7 |
|
Black or African American
|
829 |
4.6
|
828
|
6.8 |
|
American Indian/Alaska Native
|
34
|
2.7
|
34
|
4.3 |
|
Asian or Pacific Islander
|
122
|
2.2
|
122
|
3.1 |
|
Hispanic or Latino
|
388 |
2.3 |
388 |
3.7 |
|
Sources:
Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.1.4. Surveillnace, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality – All COD, Public-Use With State, Total U.S. (1969-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
US Census Bureau. United States: 2000.
|
|
Mortality
|
| |
Total Number of Deaths
|
Rate per 100,000
|
Age Group
|
|
|
20-24 years
|
16 |
0.2 |
25-29 years
|
47
|
0.5 |
30-34 years
|
161
|
1.6 |
35-39 years
|
275
|
2.4 |
40-44 years
|
391
|
3.5 |
45-49 years
|
439
|
4.3 |
50-54 years
|
455
|
5.1 |
55-59 years
|
401
|
5.8 |
60-64 years
|
324
|
5.7 |
65-69 years
|
315
|
6.1 |
70-74 years
|
315
|
6.4 |
75-79 years
|
305
|
7.0 |
80-84 years
|
223
|
7.2 |
| 85+ years |
284 |
9.4 |
|
Sources:
Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.1.4. Surveillnace, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality – All COD, Public-Use With State, Total U.S. (1969-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
US Census Bureau. United States: 2000.
|
|
Percentage of Adult Women having a Pap Smear
for Screening Purposes within the Past 3 years
|
|
Population Group
|
% with Pap Smear
|
| US Women (18 years and older) |
76.1 |
| Race/Ethnicity |
|
|
White
|
75.9 |
|
Black or African American
|
80.0 |
|
American Indian or Alaska Native
|
83.1 |
|
Asian or Pacific Islander
|
64.9 |
|
Hispanic or Latino
|
72.3 |
|
SES/Education Level
|
|
|
Less than high school
|
62.9 |
|
High school graduate or equivalent
|
72.9 |
|
At least some college
|
82.9 |
|
Source:
NHIS 2003 Sample Adult Core Survey.
|
|
|